Serum Hsa_circ_0023919 is a Predictive Biomarker of Chemoresistance in CRC Treatment

Serum Hsa_circ_0023919 is a Predictive Biomarker of Chemoresistance in CRC Treatment

Lei Zhang,1 Chuanfa Fang,1 Weiquan Zhu,1 Wu Zhong,1 Rongqiang Ye2 1Department of Gastrointestinal Hernia, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China; 2Department of Hepatobiliary and Pancreatic Surgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhang L, Fang C, Zhu W, Zhong W, Ye R
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-12-01
Series:	International Journal of General Medicine
Subjects:	hsa_circ_0023919 biomarker chemoresistance crc
Online Access:	https://www.dovepress.com/serum-hsacirc0023919-is-a-predictive-biomarker-of-chemoresistance-in-c-peer-reviewed-fulltext-article-IJGM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hsa_circ_0020095 modulates chemoresistance of CRC in a PDO model
by: Xinyu Li, et al.
Published: (2025-05-01)

Differential expression of hsa_circ_0064357 and hsa_circ_0064358 between oral squamous cell carcinoma and oral lichen planus
by: Roxana NADERI, et al.
Published: (2023-06-01)

Diagnostic value of hsa_circ_0012138 in the chronic progression of obstructive nephropathy
by: Zhichao Huang, et al.
Published: (2025-07-01)

Hsa_circ_0005571 promotes the proliferation and invasion of colorectal cancer cells
by: Haipeng Ge, et al.
Published: (2025-08-01)

To explore the role of hsa_circ_0053004/hsa-miR-646/CBX2 in diabetic retinopathy based on bioinformatics analysis and experimental verification
by: Zheng Sha, et al.
Published: (2025-03-01)

Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
by: Tang Y, et al.
Published: (2024-11-01)

Hsa_circ_0001492 regulates the hsa-miR-145-5p/ovarian carcinoma immunoreactive antigen domain 2 axis to promote the progression of lung adenocarcinoma
by: Yuanqiang He, et al.
Published: (2024-10-01)

Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis
by: Wang L, et al.
Published: (2025-07-01)

USF1-activated hsa_circ_0076691 induces oxaliplatin resistance via facilitating FGF9 expression in miR-589-3p-dependent manners
by: Lingyu Tang, et al.
Published: (2025-08-01)

Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis
by: Xiaorui Tian, et al.
Published: (2024-11-01)

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p
by: Qi Liu, et al.
Published: (2025-06-01)

Hsa-circVIM regulates breast cancer tumor progression and tamoxifen sensitivity by sponging miR-1294 in hormone receptor-positive breast cancer cells
by: Ying Chen, et al.
Published: (2025-05-01)

Hsa_circ_0006837 suppresses gastric cancer cell proliferation, migration, and invasion via the modulation of miR-424-5p
by: Yanxin He, et al.
Published: (2025-05-01)

Hsa_circ_0010957 knockdown attenuates lipopolysaccharide-induced HK2 cell injury by regulating the miR-1224-5p/IRAK1 axis
by: Jiaojiao Pan, et al.
Published: (2021-09-01)

Hsa_Circ_0105596/FTO inhibits progression of Parkinson's disease by sponging miR-187-3p and regulating eEF2
by: Jiahao Feng, et al.
Published: (2024-12-01)

Hsa_circ_0020491 promotes polycystic ovary syndrome by interacting with IGF2BP2 through regulation of granular cell autophagy and mitochondrial dysfunction
by: XiaLing Huang, et al.
Published: (2025-12-01)

Reprogramming of hsa_circ_0008719 and its target miR-3615 induced by TOB1 in exosomes of gastric cancer cells: a contribution to inhibit gastric cancer progression
by: Na Qian, et al.
Published: (2025-07-01)

Investigating the Impact of hsa_circ_0005255 on Proliferation and Autophagy in Crohn's Disease Intestinal Epithelial Cells Through miR‐23a‐3p‐Mediated NCOA3 Expression
by: Dong Liu, et al.
Published: (2025-08-01)

Local anesthetic ropivacaine inhibits non-small cell lung cancer progression by modulating the hsa_circ_0001320/miR-518a-5p axis
by: LiQun Cheng, et al.
Published: (2025-07-01)

Hsa_circFOXP1 Contributes to Breast Cancer Progression through Regulating miR-338-3p
by: Kaiding Wu, et al.
Published: (2024-05-01)

CircRNA hsa_circ_0004781 promoted cell proliferation by acting as a sponge for miR-9-5p and miR-338-3p and upregulating KLF5 and ADAM17 expression in pancreatic ductal adenocarcinoma
by: Kun-Lin Lee, et al.
Published: (2025-02-01)

Circular ribonucleic acid 0004104 as a potential biomarker and its relation to Janus kinase 2 in ulcerative colitis
by: Roaa Tarek Elbannan, et al.
Published: (2025-06-01)

Hsa_circRNA_100791 Modulates Trim13 Through Sponging miR-487b-5p to Facilitate Inflammation in Allergic Rhinitis
by: Wu J, et al.
Published: (2024-12-01)

Hsa_circ_0059511 promote glioma cell proliferation and migration through hsa-miR-194-5p/HBEGF axis
by: Yajun Jing, et al.
Published: (2025-06-01)

Expression profiles and bioinformatic analysis of circular RNA in rheumatic heart disease: potential hsa_circ_0001490 and hsa_circ_0001296 as a diagnostic biomarker
by: Xiaoliang Chen, et al.
Published: (2025-08-01)

Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
by: Yiming Chen, et al.
Published: (2025-07-01)

Identification of Plasma Exosomes hsa_circ_0001360 and hsa_circ_0000038 as Key Biomarkers of Coronary Heart Disease
by: Wan Zhang, et al.
Published: (2024-01-01)

CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
by: Canyu Liu, et al.
Published: (2025-07-01)

Study on the mechanism of hsa_circ_0074763 regulating the miR-3667-3P/ACSL4 axis in liver fibrosis
by: Yanling Cheng, et al.
Published: (2025-03-01)

The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via miR-188-5p/CDCA3/TRAF2-mediated remodeling of NF-κB signaling pathway
by: Daolin Ji, et al.
Published: (2025-07-01)

Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma
by: Jing Xu, et al.
Published: (2025-12-01)

Bioinformatics and Experimental Insights Into miR‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV‐Associated HCC
by: Yasmeen Ishaq, et al.
Published: (2024-12-01)

Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA
by: Long Qian, et al.
Published: (2025-02-01)

Identification of <i>hsa_circ_0018905</i> as a New Potential Biomarker for Multiple Sclerosis
by: Valeria Lodde, et al.
Published: (2024-10-01)

Upregulation of hsa_circ_0000745/hsa_circRNA_101996 in peripheral blood monocytes is associated with coronary heart disease
by: Li Shanshan, et al.
Published: (2025-06-01)

Circular RNA hsa_Circ_0007552 inhibits lung adenocarcinoma proliferation, migration and invasion via the miR-7974/BAP1 axis
by: Yanping Lin, et al.
Published: (2025-08-01)

Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation
by: Ganlu Deng, et al.
Published: (2025-07-01)

Study on hsa_circ_101209 in Plasma of Pregnant Women with Deep Venous Thrombosis
by: Zhang Y, et al.
Published: (2025-01-01)

Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis
by: Jianxin Tan, et al.
Published: (2025-07-01)

Hsa_circ_0000423 promotes colorectal cancer EMT and immune escape by competitive adsorption of miR-369-3p mediating CCND1 expression
by: TianFu Huang, et al.
Published: (2024-11-01)